The present article provides an overview on mucins and their role in biological processes, while aiming to familiarize readers with the current tools available for the synthesis of structurally defined mucin-type glycan probes including the advantages and potential applications of using ionic liquids in the synthesis of this important class of oligosaccharides. Furthermore, we also highlight recent developments in glycoarray technology that can enable high-sensitivity and high-throughput analysis of this important class of proteincarbohydrate interactions.
Mucins
Mucosal tissues are located in the gastrointestinal, urinary, respiratory and reproductive tracts and on the surface of the eye, and provide large surface area protection against the external environment [1] .
Mucins are glycoproteins that are present both in the mucosal fluid of the epithelial tissue and anchored to the surface of the tissue. These glycoproteins offer a plethora of potential binding sites for commensal and pathogenic microbes, and are also ligands for the targeting of leucocytes to endothelial cells. It is known that normal bacterial microflora and host interact symbiotically to maintain an effective protective barrier, but the mechanisms involved are poorly understood. More recently, evidence suggests that mucins play a role in membrane trafficking, cell signalling, and cell and tissue development and viability [2] .
Mucin glycosylation
Mucins are heavily glycosylated glycoproteins of high relative molecular mass. At least 20 different mucin glycoprotein structures have been identified in humans to date, characterized by their extreme density of O-linked oligosaccharide substitutions [1, 3] . The VNTR (variable number of tandem repeats) peptide domains are enriched in serine and threonine, which are the sites for the attachment of GalNAc (N-acetylgalactosamine); this characteristic motif is often referred to as the 'T N antigen' [4] . Glycans are extended through common core (di-or tri-saccharide) structures with a 'backbone' region, and the mucin is terminated by fucose, galactose, GalNAc or a sialic acid residue [5] . Larger molecules form either by the tandem of up to 20 units or by disulfide bridges. The length and complexity of the saccharide chains varies in accordance with the tissue and the 
chemical environment; however, it has been estimated that the carbohydrate content of the glycoproteins is high, generally consisting of 60-80% of the total relative molecular mass [3] . Eight glycan core structures have been identified (Core 1-8, Table 1 ) [1] . An important property of mucins is that they are constantly being biosynthesized and turned over, which means that the epithelial tissue can adjust rapidly to changes in the environment. The carbohydrate structures present on mucosal surfaces vary according to cell lineage, tissue location and developmental stage. Expression of certain types of O-glycans has been linked to changes in gene expression leading to inflammatory bowel disease and several types of cancer [6, 7] . Overproduction of mucins has also been linked to the morbidity and mortality of patients with chronic airway diseases such as asthma, cystic fibrosis and chronic obstructive pulmonary disease [8] . Neoplastic cells show increased levels of mucins carrying shorter carbohydrate chains because of incomplete glycosylation and one of the most prominent incomplete glycan structure is the ST N (sialyl-T N ) antigen. Mucins have recently been identified as diagnostic markers for cancer, and much research is currently devoted towards their use as therapeutic targets in neoplasia [6] . The development of immunogenic structures is therefore largely based around those directed against the ST N antigen.
Role of mucins: what we know and what we want to know
Despite their importance, little is known about the specific role of mucins in the different regions of the human intestine in both healthy and diseased states [9, 10] .
The biological importance of the Core 1-4-based structures is strongly implicated in disease development and normal host-bacteria interactions in inflammation and in the human intestinal mucosa [11] . These studies employed reagents to detect the glycosyltransferases, but only a limited range of probes were available to detect the presence of core oligosaccharides and related structures in the cells or tissues and their extracts. The assay of specific glycosyltransferase activities requires precise glycan acceptor substrates and adaptation of microarray technology to develop highthroughput methods for body fluid-, tissue-and cell-based screening regimens [12, 13] . Similarly, the need to scan catabolic pathways is well established [9] . Assay of glycohydrolase activities is also dependent on the use of appropriate substrates, and microarray screenings can be designed on the basis of knowledge of the current literature base [9] . Disruption of O-glycosylation through the action of competitive inhibitors has been described for N-acetyllactosamine disaccharide 'decoys', which have been shown to block the formation of the cancer-related glycan SLe x (sialyl-Lewis x ) through the action of the glycosyltransferase complement present in the cell line tested [14] . The glycan structures described in Figure 1 present a further family of such decoys to be tested in colorectal cell lines in line with our current studies with benzyl-O-GalNAc analogues [2] .
Further aspects of mucosal glycobiology relate to the expression of glycans as markers of disease progression and recurrence [1, 3, 6, 15] , e.g. colorectal cancer and the inflammatory bowel diseases ulcerative colitis and Crohn's disease [16] . Relevant glycan structures include the Lewis (e.g. Le x , Le y ) and sialyl-Lewis (e.g. SLe a , SLe x ) and Sd a ( Figure  1) antigens, which play a major role in cancer progression and metastasis [7, 17] , but remain to be assessed as the Core 3-and Core 4-based oligosaccharides identified in normal human intestinal mucins [18, 19] . In addition to the many glycan structures carried on glycoconjugates synthesized and turned over in body fluids, tissues and cells, families of glycan-binding proteins have been characterized. These include lectins and antibodies that recognize and bind to glycan antigens as part of normal protective processes and pathological events at the mucosal surface.
A systematic analysis of these groups of proteins and glycoconjugates has not been possible before due to the lack of specific techniques to detect the relevant oligosaccharides. Microarray technology with the new glycans provides a powerful means to assess such proteins in normal and disease situations and is well suited for high-throughput analysis.
Purification of these proteins for further characterization can be achieved using affinity matrices designed following the analysis of the microarrays.
Synthetic approaches to mucin glycans
The elucidation of glycan function remains one the most challenging areas in cell biology and is one central theme of glycomics research. In recent years, we have seen a tremendous amount of interest in the study of the structureactivity relationship of mucin-type carbohydrates and their receptors [10] .
As a result, the chemical synthesis of sufficient amounts of well-defined mucin-type oligosaccharides that can be used as probes remains essential for the investigation of these biological processes.
Initial attempts at preparing fragments of this class of O-glycans include the Schmidt's trichloroacetimidate and the Norberg's thiomethyl-based syntheses of Core 1 and Core 2 trisaccharide structures [20, 21] and Core 3 and Core 4 targets [22] . The most troublesome step in their approach is the synthesis of the α-glycosidic linkage between the 2-acetamido-2-deoxy-D-galactopyranose non-reducing end monosaccharide and the side-chain hydroxy groups of L-serine, L-threonine or an unnatural linker, which relied on the methodology introduced by Paulsen and Stenzel in 1978 [23] in which the non-participating azido group is selected as latent amino function at C-2 to afford mostly α-selective glycosylations with various donors and the OH-acceptor. (Figure 2) . A decade later, Mathieux et al. [24] reported an improved strategy for the synthesis of Core 1-4 structures, whereby an orthogonally protected galactosamine building block already containing the amino acid residue was used as the starting point, thus providing successful synthesis of all four Core 1-4 structures from one initial starting material (Figure 2 ). Although these methods did produce the core mucin structures to be used as building blocks for the synthesis of complex glycoproteins, the formation of the α-glycoside linkage between the threonine or serine residue and the carbohydrate structure was troublesome, since the stereoselective formation of cis-glycosides is one of the most challenging problems in carbohydrate chemistry and the subject of much research to date. More recently, Core 1, 2, 5, 6, 7 and 8 structures have been prepared using the 2-nitroglycan concatenation method, which allows for highly stereoselective glycoside bond formation via exclusively Michael-type addition to the nitroenol ether moiety of the 2-nitroglycals [25] . The strategy is based on the notion that glycals are enol ethers, and thus possess nucleophilic character. Glycals then can be readily transformed into the corresponding electron-poor vinyl derivatives, such as nitroglycals, which can react in Michael-type fashion with glycosyl acceptors in base-catalysed reactions to form Oglycosides.
Over the years, reports have emerged identifying some candidate mucin oligosaccharide structures that have differential expression throughout the intestinal tract [1, 2, 5, 9, 11, 15, 18] . However, and despite of all the methods developed thus far, there are no available oligosaccharide libraries of large fragments of mucin-type O-glycans ready for glycoarray conjugation, mainly due to the complexity of the targets.
As part of our programme to develop new methods and strategies for oligosaccharide synthesis, we became interested in the application of ILs (ionic liquids) for glycosylation reactions. We have recently reported the use of the IL [bmim] [OTf] as a mild and versatile (IL) recyclable solvent/promoter of room temperature glycosylation reactions using trichloroacetimidate and thiophenyl glycoside donors [26] . The conditions are mild, and compatible with a range of hydroxy and amine protecting groups, and we demonstrated further the importance of the IL counterion component to promote glycosylation reactions [27] . Furthermore, we have demonstrated that [bmim] [OTf] can promote regio-and chemo-selective glycosylation reactions at room temperature and we have shown the applicability to ambient three-component reactivity-based one-pot glycosylation reactions for the synthesis of several trisaccharides, whereby the building block reactivity is tuned by the choice of protecting groups [28] . The application of IL-catalysed reactivity-based one-pot glycosylation reactions of these important classes of O-glycans shows great promise and could potentially lead to the rapid preparation of carbohydrate-based libraries of mucin-type structures ready to be conjugated to glycoarrays for high-throughput screening.
Glycoarrays: tools for glycobiology
The biological relevance of mucin O-glycans and how synthetic chemistry can be used to provide biologists with powerful glyco-tools to screen for carbohydrate-protein interactions have been established. It is clear that, when trying to decipher the information contained in complex carbohydrates, a key demand is access to platforms that will allow for sensitive and high-throughput analyses of these important biological interactions.
Carbohydrate microarrays represent one of the most frequently used and powerful approaches to screen for carbohydrate-mediated biological processes associated with bacterial or viral infection, immune response, differentiation and many other intercellular recognition processes [29, 30] . Critically, only small amounts of analyte are required for fabricating microarrays, an important consideration due to the poor accessibility of some complex carbohydrates, and many compounds can be screened in parallel in a single operation. Moreover, experiments with carbohydratebinding proteins of the immune system such as antibodies, selectins, cytokines and chemokines have demonstrated the validity of glycoarrays to facilitate the discovery of proteins that recognize carbohydrates and to elucidate mechanisms of action [31] .
A number of approaches have been developed in the last 9 years for the fabrication of carbohydrate microarrays [7, [32] [33] [34] [35] . Wong and co-workers reported the covalent array of complex oligosaccharides containing azides or amines on glass slides and microtitre plates [36] [37] [38] , and native glycan arrays have been displayed on gold surfaces for fluorescence detection using alkyl-thiol linkers [39, 40] . Aminated oligosaccharides can also be displayed on peptide sequences on these gold surfaces for interrogation of binding and transformation [41] , an approach that can provide a more natural display of mucin glycans. Additionally, glyco-nanodots constitute a good biomimetic model of carbohydrate presentation at the cell surface and can be exploited for protein screening and imaging. Gold nanodots have been constructed by reducing a gold salt in the presence of a heterobifunctional poly(ethylene glycol) linker with a thiol group at one end and the carbohydrate moiety at the other [42] [43] [44] . Alternatively, CdTe or CdSe QDs (quantum dots) can be used as versatile inorganic probes with unique photophysical properties, i.e. narrow and size-dependent luminescence with broad absortion spectra, that offer great applicability in cellular imaging, and as nanosensors [45, 46] .
Conclusions
In summary, in order to identify and understand the role of the mucin-type O-glycans present on eukaryotic cell surfaces in both healthy and disease-state secreted mucus and the glycocalyx, we must have access to the necessary diagnostic tools, which can only be achieved via a multidisciplinary research approach that combines chemistry and molecular biology. Only then we will be able to identify the mechanisms associated with colorectal disease and bacteria-host interactions that will ultimately facilitate the identification of effective treatments for colorectal diseases and bacterial infections.
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